A false alarm, an experience
Release time:
2023-06-12
came to the corridor and found that Zhu Mouyin had also quickly escaped from the G01 workshop. We both ran down the stairs quickly at the same time. On the second floor, we met Ye Mouke and Shao Mouyi. Mixed with the mood of great nervousness and rejoicing (without fire resistance), we ran all the way to the nearest emergency evacuation assembly point in the factory area. Should a new arrival, Zhang a wide arrival, Li want to haven't arrived, will encounter any danger?
is everyone anxious, suddenly see Li want to appear from the direction of the office building. The answer was announced. It turned out that this was a fire drill led by the factory. Li wanted to be the only insider and organizer in the workshop.
Although it was just a false alarm, it is very gratifying that all of us were able to escape quickly in the correct way, and it took less than two minutes for all of us to evacuate.
Knowing the "truth", our nerves calmed down, but the drill wasn't over yet. After that, under the leadership of the exercise headquarters, the workshop carried out self-investigation and fire fighting. When I saw my friends wearing positive pressure air respirators and other protective equipment towards the fire scene, my respect and worry for the firefighters came from the moment. I am thinking that while waiting for fire rescue, we must take as many decisive, effective and necessary self-rescue measures as possible, change from passive to active, create opportunities for our own survival and escape, and reduce the difficulty of firefighters' rescue. Minimize casualties. During the
drill, the factory also invited part-time firefighters from the pharmaceutical company to explain how the fire hydrant is connected to the hose and how to use the hose to extinguish the fire. Through practical operation, I felt the strong impact of water pressure after the water valve was opened. As a non-professional, I had a brand-new fire fighting experience under the joint efforts of others.
Hidden dangers are more dangerous than open fire, prevention is better than disaster relief, and fire safety responsibility is more important than Mount Tai. In the future work, I will abandon the mentality of negligence and fluke, and be prepared for danger in times of peace and prevention. (Li Beibei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31